Early Gastric Cancer Completed Phase Trials for Rebamipide (DB11656)

IndicationStatusPhase
DBCOND0047073 (Early Gastric Cancer)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02243618The Effect of Proton Pump Inhibitor and Polaprezinc Combination Therapy for Healing of Endoscopic Submucosal Dissection-induced UlcerTreatment